Authors' response to the letter: Liver resection for patients with hepatocellular carcinoma and macrovascular invasion, multiple tumours or portal hypertension by Zhong et al

Affiliations

¹ Barcelona Clinic Liver Cancer (BCLC) Group, Liver Unit, Hospital Clinic, IDIBAPS, University of Barcelona, Barcelona, Spain Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Spain.
² Mayo Clinic, Mayo College of Medicine, Rochester, Minnesota, USA.
³ Gastrointestinal Surgery and Liver Transplantation, Istituto Nazionale Tumori IRCCS (National Cancer Institute), Milan, Italy.

Comment

Jordi Bruix et al. Gut. 2015 Mar.

. 2015 Mar;64(3):522.

doi: 10.1136/gutjnl-2014-308381. Epub 2014 Oct 13.

¹ Barcelona Clinic Liver Cancer (BCLC) Group, Liver Unit, Hospital Clinic, IDIBAPS, University of Barcelona, Barcelona, Spain Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Spain.
² Mayo Clinic, Mayo College of Medicine, Rochester, Minnesota, USA.
³ Gastrointestinal Surgery and Liver Transplantation, Istituto Nazionale Tumori IRCCS (National Cancer Institute), Milan, Italy.

No abstract available

Keywords: HEPATOCELLULAR CARCINOMA; LIVER.

Comment on

Hepatocellular carcinoma: clinical frontiers and perspectives.
Bruix J, Gores GJ, Mazzaferro V. Bruix J, et al. Gut. 2014 May;63(5):844-55. doi: 10.1136/gutjnl-2013-306627. Epub 2014 Feb 14. Gut. 2014. PMID: 24531850 Free PMC article. Review.
Liver resection for patients with hepatocellular carcinoma and macrovascular invasion, multiple tumours, or portal hypertension.
Zhong JH, Ke Y, Wang YY, Li LQ. Zhong JH, et al. Gut. 2015 Mar;64(3):520-1. doi: 10.1136/gutjnl-2014-308139. Epub 2014 Sep 3. Gut. 2015. PMID: 25187522 No abstract available.